Automated cell counters are analytical instruments used for counting and examining the physical and chemical characteristics of cells in a sample. The automated cell counters help analyze various parameters of cells such as cell size, cell structure, intracellular components, and cell density. Automated cell counters provide accurate, fast, and reproducible results and help save time during research studies related to oncology, hematology, and other cell-based assays. The growing prevalence of various cancers and the increasing research activity in the fields of immunology and stem cell therapy have accelerated the demand for automated cell counters.
The Global automated cell counters market is estimated to be valued at US$ 3.75 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, and Tecan.
The automated cell counters market is expected to witness significant growth opportunities due to the increasing prevalence of chronic and infectious diseases globally. The rising investments in cell-based research by biotechnology and pharmaceutical companies will further drive the demand.
Technological advancements in digital imaging, microfluidics, artificial intelligence, and other fields have enabled the development of highly accurate, fast, and user-friendly automated cell counters. Integration of novel technologies like deep learning and computer vision is expected to make automated cell counting more efficient and reproducible in the coming years.
Market Drivers
One of the key drivers for the growth of the automated cell counters market is the increasing research activity in the fields of immunology, stem cell research, and cancer biology. Automated cell counters play a vital role in various applications like stem cell differentiation studies, vaccine development research, and cancer diagnostics. Rising investments from private and public bodies to promote cell-based research for developing novel diagnostics and therapeutics will continue driving the demand.
Current challenges in the Automated Cell Counters Market:
The automated cell counters market is currently facing various challenges. One of the major challenges is the high cost of these counters which makes them unaffordable for small laboratories and research institutes. Another challenge is the lack of trained professionals who can properly operate these complex automated cell counters. These instruments require regular calibration and maintenance which increases the overall cost of ownership. Introducing new technologies and continuing education programmes can help overcome some of these challenges.
SWOT ANALYSIS
Strength: Advanced technology and automation reduces human errors and provides consistent and accurate cell counts. Automated systems can count cells much faster as compared to manual methods.
Weakness: High initial investment and maintenance costs of automated cell counters. Requires regular training of technical staff to operate these instruments properly.
Opportunity: Growing research in life sciences is increasing the demand for cell counting. Emerging applications in immunology and oncology will boost market opportunities. Adoption in developing countries offers potential for future growth.
Threats: Threat from used and refurbished equipment. Slow adoption rate in under-developed regions.
In terms of value, North America holds the major share in the automated cell counters market due to focus on research and presence of key players. Europe is second largest market supported by funding for R&D. Asia Pacific is emerging as the fastest growing market due to increasing life sciences research and rising healthcare expenditure in China and India. Entry of new players will further augment the APAC market.
The geographical region of Asia Pacific is expected to be the fastest growing market for automated cell counters during the forecast period from 2023 to 2030. This is attributed to increasing investments in healthcare industries by various Asian governments, rising awareness about advanced diagnostic technologies, expansion of global players into Asia and growing geriatric population in Japan and China.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
